Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Doxycycline | Case Report

Extra-urogenital infection by Mycoplasma hominis in transplant patients: two case reports and literature review

Authors: Afrinash Ahamad, Fainareti N. Zervou, Maria E. Aguero-Rosenfeld

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Mycoplasma hominis is a facultative anaerobic bacterium commonly present in the urogenital tract. In recent years, M. hominis has increasingly been associated with extra-urogenital tract infections, particularly in immunosuppressed patients. Detecting M. hominis in a diagnostic laboratory can be challenging due to its slow growth rate, absence of a cell wall, and the requirements of specialized media and conditions for optimal growth. Consequently, it is necessary to establish guidelines for the detection of this microorganism and to request the appropriate microbiological work-up of immunosuppressed patients.

Case Presentation

We hereby present two cases of solid organ transplant patients who developed M. hominis infection. Microscopic examination of the bronchial lavage and pleural fluid showed no microorganisms. However, upon inoculating the specimens onto routine microbiology media, the organism was successfully identified and confirmation was performed using 16S rDNA sequencing. Both patients received appropriate treatment resulting in the resolution of M. hominis infection.

Conclusions

The prompt detection of M. hominis in a clinical specimen can have a significant impact on patient care by allowing for early intervention and ultimately resulting in more favorable clinical outcomes, especially in transplant patients.
Literature
2.
go back to reference Pereyre S, Tardy F. Integrating the human and animal sides of Mycoplasmas Resistance to Antimicrobials. Antibiot (Basel), 2021. 10(10). Pereyre S, Tardy F. Integrating the human and animal sides of Mycoplasmas Resistance to Antimicrobials. Antibiot (Basel), 2021. 10(10).
3.
go back to reference Elias M, et al. [The presence of Mycoplasma hominis and Ureaplasma urealyticum in the cervical canal of uterus]. Ginekol Pol. 2005;76(1):28–32.PubMed Elias M, et al. [The presence of Mycoplasma hominis and Ureaplasma urealyticum in the cervical canal of uterus]. Ginekol Pol. 2005;76(1):28–32.PubMed
4.
go back to reference Stabler S et al. The brief case: Mycoplasma hominis Extragenital Abscess. J Clin Microbiol, 2021. 59(4). Stabler S et al. The brief case: Mycoplasma hominis Extragenital Abscess. J Clin Microbiol, 2021. 59(4).
5.
go back to reference Benedetti F, Curreli S, Zella D. Mycoplasmas-host Interaction: mechanisms of inflammation and Association with Cellular Transformation. Microorganisms, 2020. 8(9). Benedetti F, Curreli S, Zella D. Mycoplasmas-host Interaction: mechanisms of inflammation and Association with Cellular Transformation. Microorganisms, 2020. 8(9).
6.
go back to reference Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9(4):263–73.CrossRefPubMed Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9(4):263–73.CrossRefPubMed
8.
go back to reference Le Guern R, et al. A new case of Mycoplasma hominis mediastinitis and sternal osteitis after cardiac surgery. Int J Infect Dis. 2015;31:53–5.CrossRefPubMed Le Guern R, et al. A new case of Mycoplasma hominis mediastinitis and sternal osteitis after cardiac surgery. Int J Infect Dis. 2015;31:53–5.CrossRefPubMed
9.
go back to reference Meyer RD, Clough W. Extragenital Mycoplasma hominis Infections in adults: emphasis on Immunosuppression. Clin Infect Dis. 1993;17(Supplement1):S243–9.CrossRefPubMed Meyer RD, Clough W. Extragenital Mycoplasma hominis Infections in adults: emphasis on Immunosuppression. Clin Infect Dis. 1993;17(Supplement1):S243–9.CrossRefPubMed
10.
go back to reference Miranda C, et al. Mycoplasma hominis infection in three renal transplant patients. Diagn Microbiol Infect Dis. 1990;13(4):329–31.CrossRefPubMed Miranda C, et al. Mycoplasma hominis infection in three renal transplant patients. Diagn Microbiol Infect Dis. 1990;13(4):329–31.CrossRefPubMed
11.
go back to reference Burdge DR, et al. Septic arthritis due to dual infection with Mycoplasma hominis and Ureaplasma urealyticum. J Rheumatol. 1988;15(2):366–8.PubMed Burdge DR, et al. Septic arthritis due to dual infection with Mycoplasma hominis and Ureaplasma urealyticum. J Rheumatol. 1988;15(2):366–8.PubMed
12.
go back to reference Mufson MA. Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans. Sex Transm Dis. 1983;10(4 Suppl):335–40.PubMed Mufson MA. Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans. Sex Transm Dis. 1983;10(4 Suppl):335–40.PubMed
13.
go back to reference Dixit A, et al. Mycoplasma hominis Empyema in an 18-Year-old stem cell and lung transplant recipient: Case Report and Review of the literature. J Pediatr Infect Dis Soc. 2017;6(4):e173–6.CrossRef Dixit A, et al. Mycoplasma hominis Empyema in an 18-Year-old stem cell and lung transplant recipient: Case Report and Review of the literature. J Pediatr Infect Dis Soc. 2017;6(4):e173–6.CrossRef
15.
go back to reference Metwally MA et al. Detection, Characterization, and Molecular Typing of Human < i > Mycoplasma spp. from Major Hospitals in Cairo, Egypt The Scientific World Journal, 2014. 2014: p. 549858. Metwally MA et al. Detection, Characterization, and Molecular Typing of Human < i > Mycoplasma spp. from Major Hospitals in Cairo, Egypt The Scientific World Journal, 2014. 2014: p. 549858.
16.
go back to reference Pereyre S, et al. Life on arginine for Mycoplasma hominis: clues from its minimal genome and comparison with other human urogenital mycoplasmas. PLoS Genet. 2009;5(10):e1000677.CrossRefPubMedPubMedCentral Pereyre S, et al. Life on arginine for Mycoplasma hominis: clues from its minimal genome and comparison with other human urogenital mycoplasmas. PLoS Genet. 2009;5(10):e1000677.CrossRefPubMedPubMedCentral
17.
go back to reference Nowbakht C, et al. Two cases of fatal hyperammonemia syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients outside Lung Transplant recipients. Open Forum Infect Dis. 2019;6(3):ofz033.CrossRefPubMedPubMedCentral Nowbakht C, et al. Two cases of fatal hyperammonemia syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients outside Lung Transplant recipients. Open Forum Infect Dis. 2019;6(3):ofz033.CrossRefPubMedPubMedCentral
18.
go back to reference Delafoy M, et al. Case Report: Hyperammonemic Encephalopathy Linked to Ureaplasma spp. and/or Mycoplasma hominis systemic infection in patients treated for leukemia, an emergency not to be missed. Frontiers in Oncology; 2022. p. 12. Delafoy M, et al. Case Report: Hyperammonemic Encephalopathy Linked to Ureaplasma spp. and/or Mycoplasma hominis systemic infection in patients treated for leukemia, an emergency not to be missed. Frontiers in Oncology; 2022. p. 12.
19.
go back to reference Dawood A, et al. Mycoplasmas as host pantropic and specific pathogens: clinical implications, gene transfer, virulence factors, and future perspectives. Frontiers in Cellular and Infection Microbiology; 2022. p. 12. Dawood A, et al. Mycoplasmas as host pantropic and specific pathogens: clinical implications, gene transfer, virulence factors, and future perspectives. Frontiers in Cellular and Infection Microbiology; 2022. p. 12.
20.
21.
22.
go back to reference Divithotewala C, et al. Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: a case series and literature review. Transpl Infect Disease. 2023;n/a(n/a):pe14058.CrossRef Divithotewala C, et al. Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: a case series and literature review. Transpl Infect Disease. 2023;n/a(n/a):pe14058.CrossRef
23.
go back to reference Potruch A, et al. A Case Report of Mycoplasma hominis Subdural Empyema following decompressive craniotomy, and a review of Central Nervous System Mycoplasma hominis Infections. Front Med (Lausanne). 2022;9:792323.CrossRefPubMed Potruch A, et al. A Case Report of Mycoplasma hominis Subdural Empyema following decompressive craniotomy, and a review of Central Nervous System Mycoplasma hominis Infections. Front Med (Lausanne). 2022;9:792323.CrossRefPubMed
24.
go back to reference Waites KB, et al. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J Clin Microbiol. 2012;50(11):3542–7.CrossRefPubMedPubMedCentral Waites KB, et al. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. J Clin Microbiol. 2012;50(11):3542–7.CrossRefPubMedPubMedCentral
26.
go back to reference Boostrom I, et al. Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial. J Antimicrob Chemother. 2021;76(12):3175–82.CrossRefPubMedPubMedCentral Boostrom I, et al. Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial. J Antimicrob Chemother. 2021;76(12):3175–82.CrossRefPubMedPubMedCentral
27.
go back to reference Cunningham SA et al. Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum Int J Bacteriol, 2013. 2013: p. 168742. Cunningham SA et al. Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum Int J Bacteriol, 2013. 2013: p. 168742.
28.
go back to reference Davies S, Eggington R. Recovery of Mycoplasma hominis from blood culture media. Med Lab Sci. 1991;48(2):110–3.PubMed Davies S, Eggington R. Recovery of Mycoplasma hominis from blood culture media. Med Lab Sci. 1991;48(2):110–3.PubMed
29.
go back to reference Waites KB, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn. 2012;14(5):437–50.CrossRefPubMedPubMedCentral Waites KB, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn. 2012;14(5):437–50.CrossRefPubMedPubMedCentral
31.
go back to reference Chandler L. Thioglycollate Broth, in Accurate Results in the Clinical Laboratory. 2013. Chandler L. Thioglycollate Broth, in Accurate Results in the Clinical Laboratory. 2013.
32.
go back to reference MB DCS. Microbiology in Clinical Practice (Second Edition). 1989. p. Pages 228–263. MB DCS. Microbiology in Clinical Practice (Second Edition). 1989. p. Pages 228–263.
33.
go back to reference García C, et al. Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit. Intensive Care Med. 2007;33(1):143–7.CrossRefPubMed García C, et al. Isolation of Mycoplasma hominis in critically ill patients with pulmonary infections: clinical and microbiological analysis in an intensive care unit. Intensive Care Med. 2007;33(1):143–7.CrossRefPubMed
34.
go back to reference Potruch A, et al. A Case Report of Mycoplasma hominis Subdural Empyema following decompressive craniotomy, and a review of Central Nervous System Mycoplasma hominis Infections. Frontiers in Medicine; 2022. p. 9. Potruch A, et al. A Case Report of Mycoplasma hominis Subdural Empyema following decompressive craniotomy, and a review of Central Nervous System Mycoplasma hominis Infections. Frontiers in Medicine; 2022. p. 9.
35.
go back to reference Waites KB, Canupp KC, Kenny GE. In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. Antimicrob Agents Chemother. 1999;43(10):2571–3.CrossRefPubMedPubMedCentral Waites KB, Canupp KC, Kenny GE. In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. Antimicrob Agents Chemother. 1999;43(10):2571–3.CrossRefPubMedPubMedCentral
36.
go back to reference Roberts MC, et al. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother. 1985;28(1):141–3.CrossRefPubMedPubMedCentral Roberts MC, et al. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother. 1985;28(1):141–3.CrossRefPubMedPubMedCentral
37.
go back to reference Michel C et al. Case Report: about a case of Hyperammonemia Syndrome following lung transplantation: could Metagenomic Next-Generation sequencing improve the Clinical Management? Front Med, 2021. 8. Michel C et al. Case Report: about a case of Hyperammonemia Syndrome following lung transplantation: could Metagenomic Next-Generation sequencing improve the Clinical Management? Front Med, 2021. 8.
38.
go back to reference Lee JY, Yang JS. Prevalence and Antimicrobial susceptibility of Mycoplasma hominis and Ureaplasma Species in nonpregnant female patients in South Korea Indicate an increasing Trend of Pristinamycin-Resistant isolates. Antimicrob Agents Chemother, 2020. 64(10). Lee JY, Yang JS. Prevalence and Antimicrobial susceptibility of Mycoplasma hominis and Ureaplasma Species in nonpregnant female patients in South Korea Indicate an increasing Trend of Pristinamycin-Resistant isolates. Antimicrob Agents Chemother, 2020. 64(10).
39.
go back to reference Vecchio M, et al. Bronchial anastomosis dehiscence and stenosis caused by donor-transmitted Mycoplasma hominis infection in a lung transplant recipient: case report and literature review. Transpl Infect Dis. 2021;23(2):e13475.CrossRefPubMed Vecchio M, et al. Bronchial anastomosis dehiscence and stenosis caused by donor-transmitted Mycoplasma hominis infection in a lung transplant recipient: case report and literature review. Transpl Infect Dis. 2021;23(2):e13475.CrossRefPubMed
40.
go back to reference Chang SY, et al. Mycoplasma hominis infections in solid organ transplant recipients: clinical characteristics, treatment outcomes, and comparison of phenotypic and genotypic susceptibility profiles. Transpl Infect Dis. 2022;24(3):e13822.CrossRefPubMed Chang SY, et al. Mycoplasma hominis infections in solid organ transplant recipients: clinical characteristics, treatment outcomes, and comparison of phenotypic and genotypic susceptibility profiles. Transpl Infect Dis. 2022;24(3):e13822.CrossRefPubMed
41.
go back to reference Givone F, et al. Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: a case report and review of the literature. Transpl Infect Dis. 2020;22(2):e13249.CrossRefPubMed Givone F, et al. Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: a case report and review of the literature. Transpl Infect Dis. 2020;22(2):e13249.CrossRefPubMed
42.
go back to reference Hagiya H et al. Mycoplasma hominis periaortic abscess following heart-lung transplantation. Transpl Infect Dis, 2017. 19(3). Hagiya H et al. Mycoplasma hominis periaortic abscess following heart-lung transplantation. Transpl Infect Dis, 2017. 19(3).
43.
go back to reference Smibert OC, et al. Donor-derived Mycoplasma hominis and an apparent cluster of M. hominis cases in solid organ transplant recipients. Clin Infect Dis. 2017;65(9):1504–8.CrossRefPubMed Smibert OC, et al. Donor-derived Mycoplasma hominis and an apparent cluster of M. hominis cases in solid organ transplant recipients. Clin Infect Dis. 2017;65(9):1504–8.CrossRefPubMed
44.
go back to reference Sampath R, et al. Cardiothoracic transplant recipient Mycoplasma hominis: an uncommon infection with probable Donor transmission. EBioMedicine. 2017;19:84–90.CrossRefPubMedPubMedCentral Sampath R, et al. Cardiothoracic transplant recipient Mycoplasma hominis: an uncommon infection with probable Donor transmission. EBioMedicine. 2017;19:84–90.CrossRefPubMedPubMedCentral
45.
Metadata
Title
Extra-urogenital infection by Mycoplasma hominis in transplant patients: two case reports and literature review
Authors
Afrinash Ahamad
Fainareti N. Zervou
Maria E. Aguero-Rosenfeld
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08593-2

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine